Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Ginger Rhizome
2. Ginger Root
3. Rhizoma Zingiberis
4. Rhizoma Zingiberis Recens
5. Zingiberis Rhizoma
6. Zingiberis Rhizoma Praeparatum
7. Zingiberis Siccatum Rhizoma
1. 84696-15-1
2. (e)-1-(4-hydroxy-3-methoxyphenyl)dec-4-en-3-one;1-(4-hydroxy-3-methoxyphenyl)-5-methyldecan-3-one
| Molecular Weight | 568.8 g/mol |
|---|---|
| Molecular Formula | C35H52O6 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 19 |
| Exact Mass | 568.37638937 g/mol |
| Monoisotopic Mass | 568.37638937 g/mol |
| Topological Polar Surface Area | 93.1 Ų |
| Heavy Atom Count | 41 |
| Formal Charge | 0 |
| Complexity | 589 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
ABOUT THIS PAGE
A Ginger extract manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ginger extract, including repackagers and relabelers. The FDA regulates Ginger extract manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ginger extract API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ginger extract manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ginger extract supplier is an individual or a company that provides Ginger extract active pharmaceutical ingredient (API) or Ginger extract finished formulations upon request. The Ginger extract suppliers may include Ginger extract API manufacturers, exporters, distributors and traders.
click here to find a list of Ginger extract suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Ginger extract Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ginger extract GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ginger extract GMP manufacturer or Ginger extract GMP API supplier for your needs.
A Ginger extract CoA (Certificate of Analysis) is a formal document that attests to Ginger extract's compliance with Ginger extract specifications and serves as a tool for batch-level quality control.
Ginger extract CoA mostly includes findings from lab analyses of a specific batch. For each Ginger extract CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ginger extract may be tested according to a variety of international standards, such as European Pharmacopoeia (Ginger extract EP), Ginger extract JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ginger extract USP).
LOOKING FOR A SUPPLIER?
